Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 220-701-7 | CAS number: 2871-01-4
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Repeated dose toxicity: oral
Administrative data
- Endpoint:
- sub-chronic toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From 31 January 1979 to 30 April 1979
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- comparable to guideline study with acceptable restrictions
- Remarks:
- In this No GLP compliant study, animals were treated only 5 days per week instead of 7 required in the OECD guideline.
Data source
Reference
- Reference Type:
- publication
- Title:
- Unnamed
- Year:
- 1 986
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 408 (Repeated Dose 90-Day Oral Toxicity Study in Rodents)
- Deviations:
- yes
- Remarks:
- In this No GLP compliant study, animals were treated only 5 days per week instead of 7 required in the OECD guideline.
- GLP compliance:
- no
- Remarks:
- NTP practices
- Limit test:
- no
Test material
- Reference substance name:
- 2-(4-amino-2-nitroanilino)ethanol
- EC Number:
- 220-701-7
- EC Name:
- 2-(4-amino-2-nitroanilino)ethanol
- Cas Number:
- 2871-01-4
- Molecular formula:
- C8H11N3O3
- IUPAC Name:
- 2-(4-amino-2-nitroanilino)ethanol
- Test material form:
- solid: particulate/powder
Constituent 1
- Specific details on test material used for the study:
- SOURCE OF TEST MATERIAL
- Source and lot/batch No.of test material: 5890377
- Expiration date of the lot/batch: not specified
- Purity test date:not specifed
STABILITY AND STORAGE CONDITIONS OF TEST MATERIAL
- Storage condition of test material: stored at 22°C
- Stability under test conditions: Stable in corn oil
- Solubility and stability of the test substance in the solvent/vehicle: Stable in vehicle for 7 days at room temperature
TREATMENT OF TEST MATERIAL PRIOR TO TESTING
Appropriate amounts of HC Red No.3 and corn oil were manually shaken for 1 minute, then mixes with a magnetic stirrer until the suspension was uniform.
Test animals
- Species:
- rat
- Strain:
- Fischer 344
- Remarks:
- F344/N
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Laboratories
- Females (if applicable) nulliparous and non-pregnant:Not specified
- Age at study initiation: 7-8 weeks
- Weight at study initiation:164±2g ( males) ; 121±2 (females)
- Fasting period before study: not specified
- Housing: 5 rats were housed in polycarbonate cages
- Diet (e.g. ad libitum): Wayne Lab Blox pellets (Allied Mills) ad libitum
- Water (e.g. ad libitum): ad libitum, provided by automatic watering system
- Acclimation period: 21 days
DETAILS OF FOOD AND WATER QUALITY: Not reported
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 21-23°C
- Humidity (%): : 30-50% relative humidity
- Air changes (per hr): 15 room air chages per hour
- Photoperiod (hrs dark / hrs light): 12h fluorescent light/12 h dark
IN-LIFE DATES: From: approximately 10 January 1979 To: 6 May 1979
Administration / exposure
- Route of administration:
- oral: gavage
- Details on route of administration:
- The oral route of administration was selected for each chemical in order to provide more rigorous challenge than would be possible through dermal application.
- Vehicle:
- corn oil
- Details on oral exposure:
- PREPARATION OF DOSING SOLUTIONS:
Appropriate amounts of HC Red No.3 and corn oil were manually shaken for 1 minute, then mixes with a magnetic stirrer until the suspension was uniform.
VEHICLE
- Justification for use and choice of vehicle (if other than water): not specified
- Concentration in vehicle: not specified
- Amount of vehicle (if gavage): 5mL /kg - Analytical verification of doses or concentrations:
- yes
- Details on analytical verification of doses or concentrations:
- Doses mixture of HC Red in corn oil were analyzed periodically by spectrophotometric quantitation. It was estimated that doses were formulated within specifications 86% of the time during the 2 years study
- Duration of treatment / exposure:
- 13 weeks
- Frequency of treatment:
- Once daily, 5 days per week
Doses / concentrationsopen allclose all
- Dose / conc.:
- 0 mg/kg bw/day (nominal)
- Dose / conc.:
- 62 mg/kg bw/day (nominal)
- Dose / conc.:
- 125 mg/kg bw/day (nominal)
- Dose / conc.:
- 250 mg/kg bw/day (nominal)
- Dose / conc.:
- 500 mg/kg bw/day (nominal)
- Dose / conc.:
- 1 000 mg/kg bw/day (nominal)
- No. of animals per sex per dose:
- 10 animals were used per sex per dose.
- Control animals:
- yes
- yes, concurrent vehicle
- Details on study design:
- - Dose selection rationale: Not specified
- Rationale for animal assignment (if not random): Assigned to cage according to a table of random numbers and then to group according to an another table of random numbers
Examinations
- Observations and examinations performed and frequency:
- Animals were observed twice daily for viability and were weekly observed for clinical examination.
- Sacrifice and pathology:
- A necropsy and histopathology were performed on animals from vehicle control to 1000 mg/kg dose groups. Tissues were : gross lesions, skin, mandibular, lymph node, mammary gland, salivary gland, thigh muscle, sciatic nerve, femur including marrow, thymus, lungs and bronchi, trachea, heart, thyroid gland, parathyroids, esophagus, small intestine, colon, liver, mesenteric lymph node, inguinal lymph node, pancreas, spleen, kidneys, adrenal glands, urinary bladder, testis/epididymus/seminal vesicles/prostate or ovaries/uterus/fallopian tube/vagina, nasal cavity, brain, pituitary gland.Kidneys and Thyroid glands of rats administered 250 or 500mg/kg also examined microscopically.
- Statistics:
- Survival analysis of survival was estimated by the product limit procedure of Kaplan and Meier (1958). Statistical analyses for a possible dose-related effect on survival for a possible dose-related effect on survival used the method of Cox (1972) for testing two groups for equality and Tarone's (1975) life table test for dose related trend. All reported P value for the survival analysis were two sided.
Results and discussion
Results of examinations
- Clinical signs:
- effects observed, treatment-related
- Description (incidence and severity):
- The urine of dosed animals was orange to purple throughout the studies.
- Mortality:
- no mortality observed
- Description (incidence):
- None of the rats died before the end of the studies.
- Body weight and weight changes:
- effects observed, treatment-related
- Description (incidence and severity):
- Final body mean weights relative to vehicle controls were 7% lower for mal rats that received 1000mg/kg and 5% lower for the male rat group that received 500 mg/kg. Final body mean body weights of dosed female rats were greater then those of the vehicle controls.
- Food consumption and compound intake (if feeding study):
- not examined
- Food efficiency:
- not examined
- Water consumption and compound intake (if drinking water study):
- not examined
- Ophthalmological findings:
- not examined
- Haematological findings:
- not examined
- Clinical biochemistry findings:
- not examined
- Urinalysis findings:
- not examined
- Behaviour (functional findings):
- not examined
- Immunological findings:
- not examined
- Organ weight findings including organ / body weight ratios:
- not examined
- Gross pathological findings:
- no effects observed
- Neuropathological findings:
- not examined
- Histopathological findings: non-neoplastic:
- effects observed, treatment-related
- Description (incidence and severity):
- Granules of a brown to golden brown pigment were found in the cytoplasm of the thyroid gland follicular epithelial cells in 10/10 males and 10/10 females that received 1000 mg/kg and 10/10 males and 7/10 females that received 500 mg/kg but not in any of the rats that received 250 mg/kg. Similar pigment was found in the cytoplasm of convoluted tubular epithelial cells in the kidneys of all rats that received 1000 mg/kg, in 7/10 males and 10/10 females that received 500 mg/kg, and 6/10 males and 7/10 females that received 250 mg/kg. No other microscopic observations attributable to HC red No3 administration were noted.
- Histopathological findings: neoplastic:
- not examined
- Other effects:
- not examined
Effect levels
- Key result
- Dose descriptor:
- NOAEL
- Effect level:
- 250 mg/kg bw/day (nominal)
- Based on:
- test mat.
- Sex:
- male/female
- Basis for effect level:
- body weight and weight gain
- clinical signs
- gross pathology
- histopathology: non-neoplastic
Target system / organ toxicity
- Critical effects observed:
- no
Any other information on results incl. tables
Table1 :Summary of the results
MeanBodyWeighs(grams) |
|
|
|
|
|
|
|||
Survival |
Initial |
|
Final |
|
Change |
|
Final weight relative to control (percent) |
||
Dose (mg/kg) |
|
Mean |
SD |
Mean |
SD |
Mean |
SD |
|
|
Male |
0 |
10/10 |
164 |
2 |
357 |
5 |
193 |
5 |
|
62 |
10/10 |
159 |
4 |
352 |
4 |
193 |
4 |
98.8 |
|
|
125 |
10/10 |
161 |
4 |
350 |
6 |
189 |
4 |
98 |
250 |
10/10 |
160 |
3 |
355 |
6 |
196 |
5 |
99.6 |
|
500 |
10/10 |
134 |
5 |
338 |
6 |
184 |
4 |
94.7 |
|
1000 |
10/10 |
157 |
4 |
333 |
6 |
176 |
3 |
93.3 |
|
Female |
0 |
10/10 |
121 |
2 |
196 |
2 |
75 |
2 |
|
|
62 |
10/10 |
118 |
3 |
199 |
3 |
81 |
2 |
101.6 |
125 |
10/10 |
119 |
2 |
202 |
2 |
83 |
3 |
102.9 |
|
250 |
10/10 |
122 |
2 |
205 |
3 |
83 |
1 |
104.8 |
|
500 |
10/10 |
123 |
2 |
202 |
4 |
79 |
2 |
102.9 |
|
1000 |
10/10 |
117 |
3 |
198 |
3 |
81 |
2 |
101.0 |
|
|
Applicant's summary and conclusion
- Conclusions:
- Under the experimental conditions, the test item HC Red No.3 induced low decrease in relative bodyweight for male rats of the high dose group and of the 500 mg/kg dose group. Intense pigmentation was observed in the thyroid and kidneys at the 1000 mg/kg/ay dose group. The selected high dose for carcinogenicity test was 500 mg/kg/day. The NOAEL was defined as 250 mg/kg bw/day based on the bodyweight decrease.
- Executive summary:
The aim of the no GLP study was to investigate the potential toxicity of the test item HC Red No. 3 in rats which were exposed during 13 weeks. The study was performed in order to select appropriate doses for a 2 years carcinogenesis study.
F344/N rats were used in this study. Animals were exposed during 13 weeks, daily , 5 days per weeks. Clinical exmaination, bodyweights and morbidity observations were performed. At the termination of the study, necropsy and histopathology were performed on vehicule group and high dose group. Further analysis of thyroid and kidneys were performed.
None of the rats died before the end of the studies. The urine of dosed animals was orange to purple throughout the studies. Final body mean weights relative to vehicle controls were 7% lower for male rats that received 1000mg/kg and 5% lower for the male rat group that received 500 mg/kg. Final body mean body weights of dosed female rats were greater then those of the vehicle controls.
Granules of a brown to golden brown pigment were found in the cytoplasm of the thyroid gland follicular epithelial cells in 10/10 males and 10/10 females that received 1000 mg/kg and 10/10 males and 7/10 females that received 500 mg/kg but not in any of the rats that received 250 mg/kg. Similar pigment was found in the cytoplasm of convoluted tubular epithelial cells in the kidneys of all rats that received 1000 mg/kg, in 7/10 males and 10/10 females that received 500 mg/kg, and 6/10 males and 7/10 females that received 250 mg/kg. No other microscopic observations attributable to HC red No3 administration were noted.
Under the experimental conditions, the test item HC Red No.3 induced low decrease in relative bodyweight for male rats of the high dose group and of the 500 mg/kg dose group. Intense pigmentation was observed in the thyroid and kidneys at the 1000 mg/kg/ay dose group. The selected high dose for carcinogenicity test was 500 mg/kg/day. The NOAEL was defined as 250 mg/kg bw/day based on the bodyweight decrease. In this No GLP compliant study, animals were treated only 5 days per week instead of 7 required in the OECD guideline. Complete analysis were not performed (as haematology, clinical biochemistry, urinalysis). This study did not follow modern standard for a 90 days repeated toxicity study but was relevant for dose range finding for a chronic study.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.